Candida, a type of yeast that commonly resides in our bodies, can sometimes cause infections.
While these infections are typically localized and treatable, emerging research suggests a potential link between Candida infections and an increased risk of cancer. This article explores the existing evidence and sheds light on the possible connection.
Candida and Immune Suppression:
Candida infections, particularly those that are recurrent or persistent, have been associated with immune suppression. This occurs when the immune system is weakened, making it less effective at combating cancer cells. Studies have shown that certain Candida species can interfere with immune response, promoting a favorable environment for cancer development (1, 2).
Chronic Inflammation and Tumor Promotion:
Another mechanism by which Candida infections may contribute to cancer risk is through chronic inflammation. Prolonged inflammation can damage tissues and DNA, leading to genetic mutations and an increased likelihood of cancer development. Candida infections have been linked to chronic inflammation in various tissues, potentially creating an environment conducive to cancer growth and progression (3,4).
Association with Specific Cancer Types:
Several studies have highlighted specific cancer types that may have a higher incidence in individuals with Candida infections. For example, oral thrush caused by Candida has been associated with an increased risk of oral squamous cell carcinoma. Additionally, Candida colonization in the gastrointestinal tract has been linked to an elevated risk of colorectal cancer. However, more research is needed to establish definitive causal relationships (5,6).
Evidence suggests that certain mechanisms, such as immune suppression and chronic inflammation, may play a role. Understanding this connection could pave the way for improved cancer prevention strategies and therapeutic interventions.
Dr. Paymon Sadrolsadot, ND, PhD, is a highly skilled naturopathic physician with over 20 years of integrative medicine experience. His strong clinical background began in Iran where he received his medical degree (MD) and practiced for 7 years as a family physician. He later moved to China and completed a 5-year PhD program in Chinese Medicine and Acupuncture. Furthering his journey to natural medicine, he completed a doctorate degree of naturopathy (ND), as well as 2 years of residency program at Canadian College of Naturopathy Medicine (CCNM) in Toronto.He combines Eastern and Western medical philosophies with integrative medicine in his approach to naturopathic oncology and chronic health issues. In addition to English, Dr. Sadrolsadot speaks Mandarin and Persian.
1) Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol. 2011;14(4):386-391.
2) Sun JN, Solis NV, Phan QT, et al. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog. 2010;6(11):e1001181.
3) Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015;27(3):159-164.
4) Gullo L, Migliorati CA. Oral complications in patients with hematologic malignancies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103 Suppl:S56.e1-11.
5) Feller L, Masilana A, Khammissa RA, Altini M, Jadwat Y, Lemmer J. Oral candidosis in relation to oral squamous cell carcinoma: a review. Int J Dent. 2013;2013:904-761.
6) Koh AY. Gastrointestinal colonization by Candida species and host defense in critically ill surgical patients. Curr Opin Crit Care. 2013;19(5):460-467.